Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 2 of 2 for:    nanocovax | Covid19 | Vietnam

A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04683484
Recruitment Status : Recruiting
First Posted : December 24, 2020
Last Update Posted : December 29, 2020
Information provided by (Responsible Party):
Nanogen Pharmaceutical Biotechnology Joint Stock Company

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 10, 2021
Estimated Study Completion Date : August 10, 2021
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 14, 2021
(Canceled on June 14, 2021)
June 22, 2021
June 24, 2021
2 July 2, 2021
July 7, 2021